HUMA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Humacyte Inc

Watchlist Manager

Watchlist

Price: 1.35 USD -9.4% Market Closed

Market Cap: $299.7m

	Humacyte Inc NASDAQ:HUMA	US
	Koninklijke Ahold Delhaize NV AEX:AD	NL
V	Virax Biolabs Group Ltd NASDAQ:VRAX	UK
	Nanosonics Ltd ASX:NAN	AU
S	Shanghai Electric Group Co Ltd XBER:USR	CN
	PCI- PAL PLC F:FVA	UK
D	Daya Intiguna Yasa Tbk PT IDX:MDIY	ID
	Silvercrest Asset Management Group Inc NASDAQ:SAMG	US
E	EOG Resources Inc F:EO5	US
H	Hormel Foods Corp XBER:HO7	US
	Artisanal Spirits Company PLC F:045	UK

Profitability Summary

Humacyte Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Negative Gross Margin

-376%

Negative 3Y Average Gross Margin

-38%

Negative Operating Margin

-5 306%

Negative 3Y Average Operating Margin

-71 744%

Operating Margin is Increasing

-6 415% > -5 306%

Negative Net Margin

-2 004%

Negative 3Y Average Net Margin

-64 448%

Net Margin is Increasing

-2 188% > -2 004%

Negative Free Cash Flow Margin

-5 198%

Negative 3Y Average Free Cash Flow Margin

-61 910%

Free Cash Flow Margin is Increasing

-5 500% > -5 198%

Exceptional ROE

165%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-180%

ROIC is Increasing

-163% > -145%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.